Supernus Pharmaceuticals, Inc.
2013 Q4 - 2025 Q4 (26 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 1,282 | 0.0% | 25,802 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 898 | 0.0% | 28,486 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 849 | 0.0% | 25,909 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 913 | 0.0% | 25,241 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 812 | 0.0% | 26,038 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 710 | 0.0% | 26,554 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 842 | 0.0% | 24,684 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 721 | 0.0% | 24,912 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 711 | 0.0% | 25,793 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 606 | 0.0% | 20,162 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 718 | 0.0% | 19,827 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 704 | 0.0% | 19,736 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 660 | 0.0% | 19,506 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 574 | 0.0% | 19,831 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 654 | 0.0% | 20,237 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 732 | 0.0% | 25,110 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 688 | 0.0% | 25,800 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 854 | 0.0% | 27,729 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 729 | 0.0% | 27,859 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 745 | 0.0% | 29,605 | 12/31/2020 |
| 2020 Q3 | 11/9/2020 | 602 | 0.0% | 28,872 | 9/30/2020 |
| 2020 Q2 | 8/10/2020 | 683 | 0.0% | 29,336 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 570 | 0.0% | 31,667 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 708 | 0.0% | 29,852 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 120 | 0.0% | 13,421 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 104 | 0.0% | 13,793 | 12/31/2013 |